Parabilis Medicines, Inc.
PBLSFigures shown here come from public SEC filings. Dates beside each section show the available history.
SEC filings supply these figures; updates after the dates shown are not included. No annual financial history is available for this company. The latest insider filing shown is dated Jun 29, 2026.
Ownership
Who holds the shares, as reported in SEC ownership filings.
Purchases & sales (open market or private)
| Security | Code | Price | Filing | |||
|---|---|---|---|---|---|---|
| 2026-06-15 | SEBULSKY ALAN · Director | Common Stock | P — Open market or private purchase | +5,000 | 26.00 | SEC filing |
| 2026-06-15 | SEBULSKY ALAN · Director | Common Stock | P — Open market or private purchase | +4,065 | 27.10 | SEC filing |
| 2026-06-12 | SEBULSKY ALAN · Director | Common Stock | P — Open market or private purchase | +8,435 | 27.67 | SEC filing |
| 2026-06-11 | Soleus Capital, LLC · 10% owner | Common Stock, par value $0.0001 per share | P — Open market or private purchase | +375,000 | 20.00 | SEC filing |
| 2026-06-11 | RA Capital Healthcare Fund LP · Director, 10% owner | Voting Common Stock | P — Open market or private purchase | +1,460,397 | 20.00 | SEC filing |
| 2026-06-11 | SEBULSKY ALAN · Director | Common Stock | P — Open market or private purchase | +12,500 | 20.00 | SEC filing |
| 2026-06-11 | RA Capital Healthcare Fund LP · Director, 10% owner | Voting Common Stock | P — Open market or private purchase | +19,728,353 | 20.00 | SEC filing |
| 2026-06-11 | Soleus Capital, LLC · 10% owner | Common Stock, par value $0.0001 per share | P — Open market or private purchase | +125,000 | 20.00 | SEC filing |
Showing 8 of 8 rows
Grants, exercises, tax & gifts
| Security | Code | Filing | |||
|---|---|---|---|---|---|
| 2026-06-11 | Soleus Capital, LLC · 10% owner | Common Stock, par value $0.0001 per share | C — Conversion of derivative security | +527,070 | SEC filing |
| 2026-06-11 | DEERFIELD MANAGEMENT COMPANY, L.P. · 10% owner, other | Series C Preferred Stock | C — Conversion of derivative security | −246,732 | SEC filing |
| 2026-06-11 | DEERFIELD MANAGEMENT COMPANY, L.P. · 10% owner, other | Voting Common Stock | C — Conversion of derivative security | +260,992 | SEC filing |
| 2026-06-11 | Borisy Alexis · Director | Series F Preferred Stock | C — Conversion of derivative security | +162,221 | SEC filing |
| 2026-06-11 | DEERFIELD MANAGEMENT COMPANY, L.P. · 10% owner, other | Voting Common Stock | C — Conversion of derivative security | +407,132 | SEC filing |
| 2026-06-11 | RA Capital Healthcare Fund LP · Director, 10% owner | Series F Preferred Stock | C — Conversion of derivative security | −9,445,363 | SEC filing |
| 2026-06-11 | FITZGERALD EDWARD M · Director | Common Stock | C — Conversion of derivative security | +5,271 | SEC filing |
| 2026-06-11 | DEERFIELD MANAGEMENT COMPANY, L.P. · 10% owner, other | Voting Common Stock | C — Conversion of derivative security | +122,990 | SEC filing |
Showing 8 of 18 rows
These tables describe filed transactions, not current holdings. Prices are shown as filed; a currency is added only when the filing's data names one. Amended and possible duplicate rows are left out of size comparisons and transaction groups.